Pacific Biosciences Of California | PACB - Net Income


Pacific Biosciences Of California reported $-40.37M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Agilent USD 339M 34M Mar/2026
Bruker USD 3.5M 22.5M Mar/2026
Danaher USD 1.03B 168M Mar/2026
General Electric Aerospace USD 1.9B 637M Mar/2026
Illumina USD 134M 200M Mar/2026
Myriad Genetics USD -7.9M 19.5M Dec/2025
Pacific Biosciences Of California USD -40.37M 2.37M Dec/2025
Quidel USD -91.8M 38.9M Mar/2026
Revvity USD 40.72M 57.65M Mar/2026
Roche Holding CHF 5.47B 1.76B Dec/2025
Standard Biotools USD 19.28M 53.97M Dec/2025
Thermo Fisher Scientific USD 1.65B 313M Mar/2026
Waters USD -72M 297.21M Mar/2026